GGrantIndex
← Leaderboards

Konstantinos N Lazaridis

Mayo Clinic Rochester

$17,140,778
Attributed
$17,140,778
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$17,140,778 · 6

By mechanism

R01$8,600,752 · 3
RC2$7,763,082 · 1
K23$627,355 · 1
R03$149,589 · 1

Top collaborators

No co-investigators on record.

Most similar at Mayo Clinic Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Clinic

Research focus

ClinicResourcesEnvironmentLiver DiseasesGenomicsPathogenesisBaseGenesGeneticEnvironmental Risk FactorEnvironmental ExposureChronicQuestionnairesPrimary Biliary CirrhosisInnovationBiobankPathway InteractionsTranslational StudyGenetic VariantRegistriesFutureGenetic Predisposition To DiseaseImmunePhenotype

Grant awards (29)

Pathogenesis of Primary Biliary Cholangitis$619,745
R01 · FY2024 · DK · contact PI
Pathogenesis of Primary Biliary Cholangitis$645,568
R01 · FY2023 · DK · contact PI
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome$1,522,000
RC2 · FY2022 · DK · contact PI
Pathogenesis of Primary Biliary Cholangitis$713,529
R01 · FY2022 · DK · contact PI
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome$1,505,125
RC2 · FY2021 · DK · contact PI
Pathogenesis of Primary Biliary Cholangitis$628,683
R01 · FY2021 · DK · contact PI
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome$1,547,338
RC2 · FY2020 · DK · contact PI
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome$1,566,059
RC2 · FY2019 · DK · contact PI
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome$1,622,560
RC2 · FY2018 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$467,781
R01 · FY2015 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$468,827
R01 · FY2014 · DK · contact PI
PSC Resource Of Genetic Risk, Environment and Synergy Studies (PROGRESS)$414,787
R01 · FY2014 · DK · contact PI
PSC Resource Of Genetic Risk, Environment and Synergy Studies (PROGRESS)$551,224
R01 · FY2013 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$512,783
R01 · FY2013 · DK · contact PI
PSC Resource Of Genetic Risk, Environment and Synergy Studies (PROGRESS)$605,038
R01 · FY2012 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$296,186
R01 · FY2012 · DK · contact PI
PSC Resource Of Genetic Risk, Environment and Synergy Studies (PROGRESS)$643,143
R01 · FY2011 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$296,186
R01 · FY2011 · DK · contact PI
PSC Resource Of Genetic Risk, Environment and Synergy Studies (PROGRESS)$834,091
R01 · FY2010 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$301,445
R01 · FY2010 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$300,842
R01 · FY2009 · DK · contact PI
Genomics of Primary Biliary Cirrhosis$300,894
R01 · FY2008 · DK · contact PI
Genetic Epidemiology of Primary Biliary Cirrhosis$126,335
K23 · FY2008 · DK · contact PI
Dissecting the Aggregation of AMA in Families of PBC Patients$74,039
R03 · FY2008 · DK · contact PI
Genetic Epidemiology of Primary Biliary Cirrhosis$125,255
K23 · FY2007 · DK · contact PI
Dissecting the Aggregation of AMA in Families of PBC Patients$75,550
R03 · FY2007 · DK · contact PI
Genetic Epidemiology of Primary Biliary Cirrhosis$125,255
K23 · FY2006 · DK · contact PI
Genetic Epidemiology of Primary Biliary Cirrhosis$125,255
K23 · FY2005 · DK
Genetic Epidemiology of Primary Biliary Cirrhosis$125,255
K23 · FY2004 · DK